Screening mouse mutations for resistance to cancer metastasis

O S Egorov1, Y Liu, E E Sargent

  • 1Jackson Laboratory, Bar Harbor, ME 04609.

Immunogenetics
|January 1, 1992
PubMed

Insights

Researchers identified new mouse mutants that reveal critical genes controlling cancer metastasis. These "survivor" mutants offer a novel tool for understanding how specific genes influence tumor spread and host resistance.

Area of Science:

  • Immunogenetics
  • Cancer Biology
  • Genetics

Background:

  • Identifying host genes that regulate cancer metastasis is crucial for developing new therapies.
  • Previous studies have utilized mouse models to investigate genetic factors influencing tumor progression.

Purpose of the Study:

  • To identify and characterize host genes involved in resistance and susceptibility to cancer metastasis.
  • To generate and analyze mouse mutants with altered responses to lymphoma and sarcoma metastasis.

Main Methods:

  • Mutation analysis was performed on C57BL/6J mice to produce ten lymphoma-resistant and four sarcoma-resistant mutants (S-mutants).
  • Genetic linkage tests were conducted to determine the association of S-mutant genes with the mouse major histocompatibility complex (H-2).
  • Selected mutants were tested for resistance to spontaneous metastases of EL4 lymphoma and MCA/77-23 sarcoma.

Main Results:

  • Five S-mutants showed linkage to the H-2 locus, while five others did not.
  • Mutants S-31 (lymphoma-resisting) and S-87/2 (sarcoma-resisting) were identified as carrying mutations affecting genes for tumor metastasis resistance.
  • These identified mutants exhibited resistance to primary tumor growth but increased susceptibility to metastasis.

Conclusions:

  • The identified S-mutants represent a valuable new resource for studying genes that confer resistance to cancer metastasis.
  • These mutants facilitate the investigation of mechanisms underlying gene-controlled resistance to tumor metastasis.